Purchase-to-Pay Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 10 hours ago

Purchase-to-Pay Intern

positionWilmington, Delaware, United States of America
timeInternship
remoteOnsite
seniorityIntern
money$31/hr - $32.50/hr
workcardStart in 2026 Spring

Alexion Pharmaceuticals, Inc. is seeking Purchase-to-Pay Interns for a 12-week internship role at their Wilmington, DE site. The role involves assisting in analyzing P2P data, documenting workflows, and collaborating with global teams to improve processes and user experience.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & BenefitsbadNo H1Bnote

Responsibilities

Assist in analyzing P2P data to identify friction process and connect with improvement opportunities
Document current workflows and help design future-state processes
Collaborate with global teams to improve user experience and compliance

Qualification

Data analysisProcurement systemsProcess mappingExcelPower BICelonisLean principlesPublic speakingPresentation designMS Office 365Project management

Required

Sophomore and Junior students majoring in business administration or a related field
Proficiency in MS Office 365
Candidates must have an expected graduation date after August 2026
US Work Authorization is required at time of application
Ability to report onsite to Wilmington, DE 3-5 days per week

Preferred

Experience with data analysis and visualization tools (Excel, Power BI, Celonis) is preferred
Previous experience with procurement and finance systems in a global organization, project management, lean principles, and process mapping is a plus
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design

Company

Alexion Pharmaceuticals, Inc.

twittertwittertwitter
Glassdoor3.9
company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
dateFounded in 1992
location
Boston, Massachusetts, USA
people-size1001-5000 employees
web-link
https://alexion.com

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin

Recent News

bloomberglaw.com
AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case
2025-12-20
Business Wire
Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline and Competitive Intelligence Report 2025 - ResearchAndMarkets.com
2025-12-01
EuropaWire
AstraZeneca Secures FDA Approval for Koselugo to Treat Adults with NF1 Plexiform Neurofibromas Following Positive Phase III KOMET Results
2025-11-20
Company data provided by crunchbase